Carcinoid tumors are often described as “quiet cancers.” They grow slowly, may appear in unexpected parts of the body, and can cause subtle or easily overlooked symptoms. Because of this, many ...
Are adverse events (AEs) during first-line FOLFIRINOX (FFX) more frequent in real-world (RW) patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) who do not proceed to second-line therapy ...
Instructor in surgery, New York University College of Medicine; adjunct surgeon, Beth Israel Hospital. Edward A. Horowitz, M.D. Associate gynecologist, Beth Israel Hospital. Select the format you want ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results